---
title: "What are the therapeutic uses of monoclonal antibodies?"
summary: "Monoclonal antibodies are therapeutic agents employed in treating a range of conditions, notably cancer, autoimmune disorders, and infectious diseases."
author: "Dr. Chloe Simmons"
degree: "MSc in Biology, University of Birmingham"
tutor_type: "GCSE Biology Tutor"
date: 2024-04-27
---

Monoclonal antibodies (mAbs) are a type of laboratory-engineered molecule that emulates the immune system's capacity to combat harmful pathogens, including viruses. These antibodies are meticulously crafted to target specific cells or proteins, rendering them particularly effective for treating a variety of diseases.

One of the primary therapeutic applications of monoclonal antibodies is in oncology, where they play a crucial role in cancer treatment. mAbs achieve this by recognizing and binding to specific proteins located on the surface of cancer cells. This binding can hinder the growth and division of cancer cells or enhance their visibility to the immune system, which can subsequently mount an attack against them. Notable examples of monoclonal antibodies employed in cancer therapy include Rituximab, used for non-Hodgkin lymphoma and chronic lymphocytic leukaemia, and Trastuzumab, which is utilized for certain forms of breast cancer.

In addition to oncology, monoclonal antibodies are also employed in the management of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. In these illnesses, the immune system erroneously targets and attacks the bodyâ€™s own tissues. Monoclonal antibodies can intervene by blocking the actions of specific cells or proteins that contribute to this misguided immune response. For instance, Adalimumab and Infliximab are monoclonal antibodies that inhibit a protein known as tumor necrosis factor-alpha (TNF-alpha), which is pivotal in driving inflammation associated with rheumatoid arthritis.

Furthermore, monoclonal antibodies are instrumental in addressing infectious diseases. They can be engineered to specifically target certain viruses or bacteria, thereby preventing them from infecting cells and propagating within the body. This targeted approach has facilitated the development of treatments for diseases such as HIV and Ebola. A notable example is the monoclonal antibody ZMapp, which has been utilized in the treatment of Ebola virus disease.

In summary, monoclonal antibodies have diverse therapeutic applications ranging from cancer treatment and the management of autoimmune disorders to combating infectious diseases. Their ability to specifically target cells or proteins positions them as a formidable asset in contemporary medicine.
    